Encompass Health Corporation
HealthcareNYSE:EHC · New York Stock Exchange
-$0.91 today
Vol 0.68M · Avg 0.92M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
23.2%
avg 23.8%
ROIC
13.3%
avg 10.7%
ROA
8.0%
avg 5.7%
Analysis
ROE is currently the strongest return metric at 23.2% versus its period average of 23.8%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Mark J. Tarr | Chief Executive Officer, President & Director | $3.85M | — | 64 | $11,563.00 | 0.01% |
Douglas E. Coltharp | Executive Vice President & Chief Financial Officer | $2.10M | — | 64 | $97,071.00 | 0.10% |
John Patrick Darby | Executive Vice President, General Counsel & Corporate Secretary | $1.51M | — | 61 | $24,755.00 | 0.02% |
Patrick W. Tuer | EVP & Chief Operating Officer | $1.42M | — | 41 | $24,755.00 | 0.02% |
Elissa Joy Charbonneau | Chief Medical Officer | $926,131.00 | — | 66 | $17,644.06 | 0.02% |
Andrew L. Price | Senior Vice President & Chief Accounting Officer | $656,326.00 | — | 59 | $74,694.00 | 0.08% |
Mark Miller | Senior Vice President of Investor Relations & Strategic Planning | — | — | — | $35,461.00 | 0.04% |
Rusty Yeager | Chief Information Officer & Senior Vice President | — | — | — | — | — |
Dawn Rock | Chief Compliance Officer | — | — | — | — | — |
Anthony A. Hernandez | Chief Human Resources Officer | — | — | 60 | $548,842.00 | 0.55% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
13
$21.48M
Net Sentiment
$21.48M
Net selling
Most Active
Tarr Mark J
7 transactions
1–10 of 13
Analysis
Insiders reported 0 buys worth $0.00 and 13 sells worth $21.48M over the last 12 months. That adds up to net selling of $21.48M. Tarr Mark J was the most active insider with 7 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +4.6% | +11.0% (15yr)1 analysts |
| Revenue | N/A | N/A | +13.4% | +7.3% (15yr)2 analysts |
| Net Income | N/A | N/A | -0.3% | +11.5% (15yr)2 analysts |
| EBIT | N/A | N/A | +10.3% | +6.6% (15yr)2 analysts |
Analysis
Recent growth has been strongest in Revenue at +13.4% over three years. Forward estimates point to Net Income at +11.5% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Solventum Corporation
NYSE:SOLV
$13.66B
DaVita Inc.
NYSE:DVA
$13.40B
Align Technology, Inc.
NASDAQ:ALGN
$12.52B
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
$12.36B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.07B
ICON Public Limited Company
NASDAQ:ICLR
$11.19B
Dr. Reddy's Laboratories Limited
NYSE:RDY
$11.07B
Universal Health Services, Inc.
NYSE:UHS
$9.17B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.73B
Chemed Corporation
NYSE:CHE
$5.57B
Who manages EHC?
Encompass Health Corporation (EHC) lists 10 active executives. The top listed executive is Mark J. Tarr, Chief Executive Officer, President & Director.
Are EHC insiders buying or selling?
Recent insider activity shows net selling of $49.57M.
Explore More
Continue the stock analysis
Jump to another research area for this company.